Patents by Inventor Robert Francis Dunn

Robert Francis Dunn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESSES FOR THE PREPARATION OF (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE
    Publication number: 20240228475
    Abstract: Provided herein are processes for the preparation of (S)-2-(2,6-dioxopipelidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl) methyl) benzyl)amino)isoindoline-1, 3-dione, or a salt, solvate, hydrate, enantiomer, mixture of enantiomers, or isotopologue thereof, which is useful for treating, preventing, and managing various disorders. Also provided are solid forms of various intermediates and products obtained from the processes.
    Type: Application
    Filed: June 17, 2022
    Publication date: July 11, 2024
    Inventors: Ronald CARRASQUILLO-FLORES, Jian CHEN, Patrick CORONA, David DEL VALLE, Robert Francis DUNN, Megan EMMANUEL, Antonio C. FERRETTI, Richard Martin HEID, Amude KASSIM, Mohit KOTHARE, Wei LIU, Geoffrey Eugene PURDUM, Krishnakumar RANGANATHAN, Paula A. TAVARES-GRECO, Kelvin Hin-Yeong YONG, Yong YU, Chengmin ZHANG
  • PHOSPHODIESTERASE 4 INHIBITORS
    Publication number: 20090306156
    Abstract: Selective PDE4 inhibition is achieved by novel compounds, e.g., 4-(substituted-phenyl)-2-pyrrolidinone compounds. The compounds of the present invention are of formula I: wherein R1, R2, and R3 are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
    Type: Application
    Filed: August 4, 2009
    Publication date: December 10, 2009
    Inventors: Allen HOPPER, Robert Francis Dunn, Erik Mikal Kuester, Richard Dennis Conticello, Ruiping Liu, Ashok Tehim
  • Phosphodiesterase 4 inhibitors
    Patent number: 7585882
    Abstract: Selective PDE4 inhibition is achieved by novel compounds, e.g., 4-(substituted-phenyl)-2-pyrrolidinone compounds. The compounds of the present invention are of formula I: wherein R1, R2, and R3 are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
    Type: Grant
    Filed: October 20, 2005
    Date of Patent: September 8, 2009
    Assignee: Memory Pharmaceuticals Corporation
    Inventors: Allen Hopper, Robert Francis Dunn, Erik Mikal Kuester, Richard Dennis Conticello, Ruiping Liu, Ashok Tehim